Lixiao Xing

机构：Shanghai Medical College of Fudan University · ORCID：0000-0002-3027-1325

发表论文 19 篇 · 总被引 474 次 · h-index 12

代表论文

• A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs (2022 · Cell Research · 被引 113)
• STING agonist-based ER-targeting molecules boost antigen cross-presentation (2025 · Nature · 被引 65)
• Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target (2025 · Cell · 被引 47)
• A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern (2022 · Viruses · 被引 42)
• A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases (2021 · Acta Pharmaceutica Sinica B · 被引 37)
• Development and application of a colloidal gold test strip for detection of avian leukosis virus (2018 · Applied Microbiology and Biotechnology · 被引 27)